nodes	percent_of_prediction	percent_of_DWPC	metapath
Propylthiouracil—DIO1—Thyroxine biosynthesis—SLC5A5—melanoma	0.0481	0.0837	CbGpPWpGaD
Propylthiouracil—TPO—Thyroxine (Thyroid Hormone) Production—SLC5A5—melanoma	0.0348	0.0605	CbGpPWpGaD
Propylthiouracil—TPO—Thyroxine biosynthesis—SLC5A5—melanoma	0.0276	0.0481	CbGpPWpGaD
Propylthiouracil—DIO1—Amine-derived hormones—SLC5A5—melanoma	0.0276	0.0481	CbGpPWpGaD
Propylthiouracil—Erythema nodosum—Vemurafenib—melanoma	0.0257	0.0603	CcSEcCtD
Propylthiouracil—Pigmentation disorder—Temozolomide—melanoma	0.017	0.04	CcSEcCtD
Propylthiouracil—DBH—Amine-derived hormones—SLC5A5—melanoma	0.0169	0.0294	CbGpPWpGaD
Propylthiouracil—DIO1—Selenium Micronutrient Network—PRDX2—melanoma	0.0164	0.0286	CbGpPWpGaD
Propylthiouracil—TPO—Amine-derived hormones—SLC5A5—melanoma	0.0159	0.0276	CbGpPWpGaD
Propylthiouracil—Traumatic liver injury—Temozolomide—melanoma	0.0152	0.0358	CcSEcCtD
Propylthiouracil—Lung infiltration—Bleomycin—melanoma	0.0144	0.0337	CcSEcCtD
Propylthiouracil—MPO—IL23-mediated signaling events—IL24—melanoma	0.0139	0.0242	CbGpPWpGaD
Propylthiouracil—TPO—Hematopoietic Stem Cell Differentiation—CSF3—melanoma	0.013	0.0227	CbGpPWpGaD
Propylthiouracil—Lung infiltration—Carmustine—melanoma	0.0125	0.0294	CcSEcCtD
Propylthiouracil—MPO—IL23-mediated signaling events—CXCL1—melanoma	0.0118	0.0206	CbGpPWpGaD
Propylthiouracil—Interstitial pneumonia—Temozolomide—melanoma	0.0118	0.0276	CcSEcCtD
Propylthiouracil—TPO—Differentiation Pathway—NODAL—melanoma	0.0116	0.0202	CbGpPWpGaD
Propylthiouracil—Vasculitis—Vemurafenib—melanoma	0.0114	0.0267	CcSEcCtD
Propylthiouracil—Drug fever—Docetaxel—melanoma	0.0113	0.0266	CcSEcCtD
Propylthiouracil—TPO—Differentiation Pathway—CXCR1—melanoma	0.0112	0.0196	CbGpPWpGaD
Propylthiouracil—Interstitial lung disease—Bleomycin—melanoma	0.00951	0.0223	CcSEcCtD
Propylthiouracil—TPO—Differentiation Pathway—WNT5A—melanoma	0.00852	0.0148	CbGpPWpGaD
Propylthiouracil—DIO1—Amino acid and derivative metabolism—SLC6A11—melanoma	0.00841	0.0146	CbGpPWpGaD
Propylthiouracil—Interstitial lung disease—Carmustine—melanoma	0.0083	0.0195	CcSEcCtD
Propylthiouracil—DIO1—Amino acid and derivative metabolism—MTAP—melanoma	0.00818	0.0143	CbGpPWpGaD
Propylthiouracil—Interstitial lung disease—Temozolomide—melanoma	0.00802	0.0188	CcSEcCtD
Propylthiouracil—TPO—Hematopoietic Stem Cell Differentiation—EPO—melanoma	0.00799	0.0139	CbGpPWpGaD
Propylthiouracil—Interstitial pneumonia—Docetaxel—melanoma	0.00782	0.0184	CcSEcCtD
Propylthiouracil—TPO—Hematopoietic Stem Cell Differentiation—CXCR4—melanoma	0.00744	0.013	CbGpPWpGaD
Propylthiouracil—DIO1—Amino acid and derivative metabolism—PHGDH—melanoma	0.00729	0.0127	CbGpPWpGaD
Propylthiouracil—MPO—Vitamin B12 Metabolism—CUBN—melanoma	0.00718	0.0125	CbGpPWpGaD
Propylthiouracil—TPO—Differentiation Pathway—EPO—melanoma	0.0069	0.012	CbGpPWpGaD
Propylthiouracil—DBH—Monoamine Transport—ITGB3—melanoma	0.0068	0.0118	CbGpPWpGaD
Propylthiouracil—Liver injury—Temozolomide—melanoma	0.00675	0.0158	CcSEcCtD
Propylthiouracil—Neuropathy peripheral—Vemurafenib—melanoma	0.00609	0.0143	CcSEcCtD
Propylthiouracil—MPO—Selenium Micronutrient Network—PRDX2—melanoma	0.00591	0.0103	CbGpPWpGaD
Propylthiouracil—Aplastic anaemia—Dactinomycin—melanoma	0.0059	0.0138	CcSEcCtD
Propylthiouracil—TPO—Hematopoietic Stem Cell Differentiation—CSF2—melanoma	0.00558	0.00971	CbGpPWpGaD
Propylthiouracil—TPO—Hematopoietic Stem Cell Differentiation—ITGB3—melanoma	0.00535	0.00931	CbGpPWpGaD
Propylthiouracil—Interstitial lung disease—Docetaxel—melanoma	0.00534	0.0125	CcSEcCtD
Propylthiouracil—Aplastic anaemia—Temozolomide—melanoma	0.00533	0.0125	CcSEcCtD
Propylthiouracil—DBH—Amino acid and derivative metabolism—SLC6A11—melanoma	0.00514	0.00895	CbGpPWpGaD
Propylthiouracil—Hepatic failure—Dactinomycin—melanoma	0.00507	0.0119	CcSEcCtD
Propylthiouracil—Neuritis—Docetaxel—melanoma	0.00506	0.0119	CcSEcCtD
Propylthiouracil—DBH—Amino acid and derivative metabolism—MTAP—melanoma	0.005	0.00871	CbGpPWpGaD
Propylthiouracil—Alopecia—Vemurafenib—melanoma	0.00493	0.0116	CcSEcCtD
Propylthiouracil—TPO—Differentiation Pathway—HGF—melanoma	0.00487	0.00849	CbGpPWpGaD
Propylthiouracil—TPO—Amino acid and derivative metabolism—SLC6A11—melanoma	0.00483	0.00841	CbGpPWpGaD
Propylthiouracil—TPO—Differentiation Pathway—FGF1—melanoma	0.00482	0.00839	CbGpPWpGaD
Propylthiouracil—Dysgeusia—Vemurafenib—melanoma	0.00476	0.0112	CcSEcCtD
Propylthiouracil—TPO—Amino acid and derivative metabolism—MTAP—melanoma	0.0047	0.00818	CbGpPWpGaD
Propylthiouracil—Ageusia—Docetaxel—melanoma	0.00466	0.0109	CcSEcCtD
Propylthiouracil—Hepatic failure—Temozolomide—melanoma	0.00459	0.0108	CcSEcCtD
Propylthiouracil—MPO—C-MYB transcription factor network—SKI—melanoma	0.0045	0.00784	CbGpPWpGaD
Propylthiouracil—DBH—Amino acid and derivative metabolism—PHGDH—melanoma	0.00445	0.00776	CbGpPWpGaD
Propylthiouracil—Dermatitis exfoliative—Temozolomide—melanoma	0.00437	0.0103	CcSEcCtD
Propylthiouracil—TPO—Hematopoietic Stem Cell Differentiation—NOTCH1—melanoma	0.00428	0.00746	CbGpPWpGaD
Propylthiouracil—DIO1—Selenium Metabolism and Selenoproteins—NFKB1—melanoma	0.00422	0.00736	CbGpPWpGaD
Propylthiouracil—TPO—Amino acid and derivative metabolism—PHGDH—melanoma	0.00419	0.0073	CbGpPWpGaD
Propylthiouracil—Arthralgia—Vemurafenib—melanoma	0.00414	0.00971	CcSEcCtD
Propylthiouracil—Myalgia—Vemurafenib—melanoma	0.00414	0.00971	CcSEcCtD
Propylthiouracil—DIO1—Selenium Micronutrient Network—ICAM1—melanoma	0.00404	0.00703	CbGpPWpGaD
Propylthiouracil—DIO1—Amino acid and derivative metabolism—SLC5A5—melanoma	0.00385	0.0067	CbGpPWpGaD
Propylthiouracil—TPO—Differentiation Pathway—NOTCH1—melanoma	0.0037	0.00645	CbGpPWpGaD
Propylthiouracil—TPO—Differentiation Pathway—KIT—melanoma	0.00362	0.0063	CbGpPWpGaD
Propylthiouracil—Musculoskeletal discomfort—Vemurafenib—melanoma	0.00361	0.00848	CcSEcCtD
Propylthiouracil—TPO—Differentiation Pathway—EGF—melanoma	0.00358	0.00623	CbGpPWpGaD
Propylthiouracil—Haemoglobin—Bleomycin—melanoma	0.0034	0.00798	CcSEcCtD
Propylthiouracil—Haemorrhage—Bleomycin—melanoma	0.00338	0.00794	CcSEcCtD
Propylthiouracil—DIO1—Selenium Micronutrient Network—ALB—melanoma	0.00337	0.00587	CbGpPWpGaD
Propylthiouracil—TPO—Differentiation Pathway—IGF1—melanoma	0.00331	0.00577	CbGpPWpGaD
Propylthiouracil—Agranulocytosis—Dactinomycin—melanoma	0.00328	0.0077	CcSEcCtD
Propylthiouracil—Neuropathy peripheral—Carmustine—melanoma	0.00322	0.00757	CcSEcCtD
Propylthiouracil—Hepatitis—Dactinomycin—melanoma	0.00315	0.0074	CcSEcCtD
Propylthiouracil—MPO—C-MYB transcription factor network—ETS1—melanoma	0.00314	0.00547	CbGpPWpGaD
Propylthiouracil—Body temperature increased—Vemurafenib—melanoma	0.00313	0.00736	CcSEcCtD
Propylthiouracil—Neuropathy peripheral—Temozolomide—melanoma	0.00311	0.00731	CcSEcCtD
Propylthiouracil—DIO1—Selenium Micronutrient Network—IFNG—melanoma	0.00307	0.00535	CbGpPWpGaD
Propylthiouracil—Hepatic failure—Docetaxel—melanoma	0.00305	0.00716	CcSEcCtD
Propylthiouracil—TPO—Differentiation Pathway—FGF2—melanoma	0.00305	0.00531	CbGpPWpGaD
Propylthiouracil—Alopecia—Bleomycin—melanoma	0.00299	0.00702	CcSEcCtD
Propylthiouracil—Haemoglobin—Carmustine—melanoma	0.00297	0.00697	CcSEcCtD
Propylthiouracil—Haemorrhage—Carmustine—melanoma	0.00295	0.00693	CcSEcCtD
Propylthiouracil—DIO1—Selenium Micronutrient Network—PTGS2—melanoma	0.00295	0.00513	CbGpPWpGaD
Propylthiouracil—MPO—IL23-mediated signaling events—NOS2—melanoma	0.00288	0.00502	CbGpPWpGaD
Propylthiouracil—Haemoglobin—Temozolomide—melanoma	0.00287	0.00673	CcSEcCtD
Propylthiouracil—Hepatitis—Temozolomide—melanoma	0.00285	0.0067	CcSEcCtD
Propylthiouracil—Haemorrhage—Temozolomide—melanoma	0.00285	0.0067	CcSEcCtD
Propylthiouracil—Pruritus—Vemurafenib—melanoma	0.00281	0.00659	CcSEcCtD
Propylthiouracil—Alopecia—Dactinomycin—melanoma	0.00279	0.00654	CcSEcCtD
Propylthiouracil—DBH—Monoamine Transport—TNF—melanoma	0.00273	0.00475	CbGpPWpGaD
Propylthiouracil—Leukopenia—Bleomycin—melanoma	0.00263	0.00619	CcSEcCtD
Propylthiouracil—Alopecia—Carmustine—melanoma	0.00261	0.00612	CcSEcCtD
Propylthiouracil—DIO1—Selenium Micronutrient Network—NFKB1—melanoma	0.00256	0.00445	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—ACER3—melanoma	0.00255	0.00444	CbGpPWpGaD
Propylthiouracil—Vomiting—Vemurafenib—melanoma	0.00252	0.00592	CcSEcCtD
Propylthiouracil—Alopecia—Temozolomide—melanoma	0.00252	0.00592	CcSEcCtD
Propylthiouracil—Myalgia—Bleomycin—melanoma	0.00251	0.00588	CcSEcCtD
Propylthiouracil—Rash—Vemurafenib—melanoma	0.0025	0.00587	CcSEcCtD
Propylthiouracil—Dermatitis—Vemurafenib—melanoma	0.0025	0.00587	CcSEcCtD
Propylthiouracil—Headache—Vemurafenib—melanoma	0.00248	0.00583	CcSEcCtD
Propylthiouracil—Leukopenia—Dactinomycin—melanoma	0.00246	0.00577	CcSEcCtD
Propylthiouracil—Dysgeusia—Temozolomide—melanoma	0.00243	0.00571	CcSEcCtD
Propylthiouracil—Oedema—Bleomycin—melanoma	0.0024	0.00564	CcSEcCtD
Propylthiouracil—Nausea—Vemurafenib—melanoma	0.00236	0.00553	CcSEcCtD
Propylthiouracil—Thrombocytopenia—Bleomycin—melanoma	0.00235	0.00552	CcSEcCtD
Propylthiouracil—DBH—Amino acid and derivative metabolism—SLC5A5—melanoma	0.00235	0.00409	CbGpPWpGaD
Propylthiouracil—Myalgia—Dactinomycin—melanoma	0.00234	0.00549	CcSEcCtD
Propylthiouracil—DIO1—Metabolism—UGT2B10—melanoma	0.00233	0.00406	CbGpPWpGaD
Propylthiouracil—MPO—Folate Metabolism—IL4—melanoma	0.0023	0.00401	CbGpPWpGaD
Propylthiouracil—Leukopenia—Carmustine—melanoma	0.0023	0.0054	CcSEcCtD
Propylthiouracil—MPO—Vitamin B12 Metabolism—ICAM1—melanoma	0.00225	0.00392	CbGpPWpGaD
Propylthiouracil—Oedema—Dactinomycin—melanoma	0.00224	0.00526	CcSEcCtD
Propylthiouracil—Vertigo—Temozolomide—melanoma	0.00223	0.00524	CcSEcCtD
Propylthiouracil—Leukopenia—Temozolomide—melanoma	0.00222	0.00522	CcSEcCtD
Propylthiouracil—MPO—IL23-mediated signaling events—IFNG—melanoma	0.00221	0.00385	CbGpPWpGaD
Propylthiouracil—TPO—Amino acid and derivative metabolism—SLC5A5—melanoma	0.00221	0.00385	CbGpPWpGaD
Propylthiouracil—Thrombocytopenia—Dactinomycin—melanoma	0.00219	0.00515	CcSEcCtD
Propylthiouracil—Musculoskeletal discomfort—Bleomycin—melanoma	0.00219	0.00514	CcSEcCtD
Propylthiouracil—Myalgia—Carmustine—melanoma	0.00219	0.00514	CcSEcCtD
Propylthiouracil—DIO1—Metabolism—HS3ST5—melanoma	0.00217	0.00378	CbGpPWpGaD
Propylthiouracil—TPO—Differentiation Pathway—VEGFA—melanoma	0.00216	0.00377	CbGpPWpGaD
Propylthiouracil—Paraesthesia—Bleomycin—melanoma	0.00216	0.00507	CcSEcCtD
Propylthiouracil—MPO—IL23-mediated signaling events—CD4—melanoma	0.00214	0.00372	CbGpPWpGaD
Propylthiouracil—Arthralgia—Temozolomide—melanoma	0.00211	0.00496	CcSEcCtD
Propylthiouracil—Myalgia—Temozolomide—melanoma	0.00211	0.00496	CcSEcCtD
Propylthiouracil—Oedema—Carmustine—melanoma	0.0021	0.00492	CcSEcCtD
Propylthiouracil—Neuropathy peripheral—Docetaxel—melanoma	0.00207	0.00486	CcSEcCtD
Propylthiouracil—Jaundice—Docetaxel—melanoma	0.00206	0.00484	CcSEcCtD
Propylthiouracil—Thrombocytopenia—Carmustine—melanoma	0.00205	0.00482	CcSEcCtD
Propylthiouracil—Musculoskeletal discomfort—Dactinomycin—melanoma	0.00204	0.00479	CcSEcCtD
Propylthiouracil—Oedema—Temozolomide—melanoma	0.00203	0.00476	CcSEcCtD
Propylthiouracil—DIO1—Selenium Micronutrient Network—TNF—melanoma	0.00199	0.00346	CbGpPWpGaD
Propylthiouracil—Thrombocytopenia—Temozolomide—melanoma	0.00198	0.00466	CcSEcCtD
Propylthiouracil—Agranulocytosis—Docetaxel—melanoma	0.00197	0.00463	CcSEcCtD
Propylthiouracil—MPO—IL23-mediated signaling events—IL2—melanoma	0.00197	0.00342	CbGpPWpGaD
Propylthiouracil—Musculoskeletal discomfort—Carmustine—melanoma	0.00191	0.00449	CcSEcCtD
Propylthiouracil—Urticaria—Bleomycin—melanoma	0.00191	0.00448	CcSEcCtD
Propylthiouracil—Haemoglobin—Docetaxel—melanoma	0.00191	0.00448	CcSEcCtD
Propylthiouracil—Body temperature increased—Bleomycin—melanoma	0.0019	0.00446	CcSEcCtD
Propylthiouracil—Hepatitis—Docetaxel—melanoma	0.0019	0.00445	CcSEcCtD
Propylthiouracil—Haemorrhage—Docetaxel—melanoma	0.0019	0.00445	CcSEcCtD
Propylthiouracil—Paraesthesia—Carmustine—melanoma	0.00188	0.00442	CcSEcCtD
Propylthiouracil—MPO—Vitamin B12 Metabolism—ALB—melanoma	0.00188	0.00327	CbGpPWpGaD
Propylthiouracil—Somnolence—Carmustine—melanoma	0.00186	0.00438	CcSEcCtD
Propylthiouracil—Musculoskeletal discomfort—Temozolomide—melanoma	0.00185	0.00434	CcSEcCtD
Propylthiouracil—MPO—IL23-mediated signaling events—NFKB1—melanoma	0.00184	0.00321	CbGpPWpGaD
Propylthiouracil—MPO—Folate Metabolism—ICAM1—melanoma	0.00183	0.00319	CbGpPWpGaD
Propylthiouracil—Paraesthesia—Temozolomide—melanoma	0.00182	0.00427	CcSEcCtD
Propylthiouracil—Somnolence—Temozolomide—melanoma	0.0018	0.00423	CcSEcCtD
Propylthiouracil—Dyspepsia—Temozolomide—melanoma	0.00178	0.00419	CcSEcCtD
Propylthiouracil—Body temperature increased—Dactinomycin—melanoma	0.00177	0.00416	CcSEcCtD
Propylthiouracil—TPO—Hematopoietic Stem Cell Differentiation—IL6—melanoma	0.00173	0.00302	CbGpPWpGaD
Propylthiouracil—MPO—Vitamin B12 Metabolism—IFNG—melanoma	0.00171	0.00298	CbGpPWpGaD
Propylthiouracil—Pruritus—Bleomycin—melanoma	0.0017	0.00399	CcSEcCtD
Propylthiouracil—Alopecia—Docetaxel—melanoma	0.00168	0.00394	CcSEcCtD
Propylthiouracil—Body temperature increased—Carmustine—melanoma	0.00166	0.00389	CcSEcCtD
Propylthiouracil—MPO—IL23-mediated signaling events—STAT3—melanoma	0.00165	0.00288	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—PLCB4—melanoma	0.00164	0.00286	CbGpPWpGaD
Propylthiouracil—Dysgeusia—Docetaxel—melanoma	0.00162	0.0038	CcSEcCtD
Propylthiouracil—Urticaria—Temozolomide—melanoma	0.00161	0.00378	CcSEcCtD
Propylthiouracil—DIO1—Selenium Micronutrient Network—IL6—melanoma	0.0016	0.0028	CbGpPWpGaD
Propylthiouracil—Body temperature increased—Temozolomide—melanoma	0.0016	0.00376	CcSEcCtD
Propylthiouracil—DBH—Metabolism—ACER3—melanoma	0.00156	0.00271	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—SLC6A11—melanoma	0.00154	0.00269	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—PIP4K2A—melanoma	0.00154	0.00269	CbGpPWpGaD
Propylthiouracil—Vomiting—Bleomycin—melanoma	0.00153	0.00359	CcSEcCtD
Propylthiouracil—MPO—Folate Metabolism—ALB—melanoma	0.00153	0.00266	CbGpPWpGaD
Propylthiouracil—Rash—Bleomycin—melanoma	0.00151	0.00356	CcSEcCtD
Propylthiouracil—Dermatitis—Bleomycin—melanoma	0.00151	0.00355	CcSEcCtD
Propylthiouracil—DIO1—Metabolism—MTAP—melanoma	0.0015	0.00262	CbGpPWpGaD
Propylthiouracil—TPO—Differentiation Pathway—IL6—melanoma	0.0015	0.00261	CbGpPWpGaD
Propylthiouracil—Leukopenia—Docetaxel—melanoma	0.00148	0.00347	CcSEcCtD
Propylthiouracil—TPO—Metabolism—ACER3—melanoma	0.00146	0.00255	CbGpPWpGaD
Propylthiouracil—MPO—Selenium Micronutrient Network—ICAM1—melanoma	0.00145	0.00253	CbGpPWpGaD
Propylthiouracil—MPO—C-MYB transcription factor network—KIT—melanoma	0.00145	0.00253	CbGpPWpGaD
Propylthiouracil—Pruritus—Temozolomide—melanoma	0.00143	0.00337	CcSEcCtD
Propylthiouracil—MPO—IL23-mediated signaling events—TNF—melanoma	0.00143	0.00249	CbGpPWpGaD
Propylthiouracil—Nausea—Bleomycin—melanoma	0.00143	0.00335	CcSEcCtD
Propylthiouracil—Vomiting—Dactinomycin—melanoma	0.00142	0.00334	CcSEcCtD
Propylthiouracil—DBH—Metabolism—UGT2B10—melanoma	0.00142	0.00248	CbGpPWpGaD
Propylthiouracil—MPO—Vitamin B12 Metabolism—NFKB1—melanoma	0.00142	0.00248	CbGpPWpGaD
Propylthiouracil—Rash—Dactinomycin—melanoma	0.00141	0.00332	CcSEcCtD
Propylthiouracil—Arthralgia—Docetaxel—melanoma	0.00141	0.0033	CcSEcCtD
Propylthiouracil—Myalgia—Docetaxel—melanoma	0.00141	0.0033	CcSEcCtD
Propylthiouracil—MPO—Folate Metabolism—IFNG—melanoma	0.00139	0.00243	CbGpPWpGaD
Propylthiouracil—Oedema—Docetaxel—melanoma	0.00135	0.00316	CcSEcCtD
Propylthiouracil—DIO1—Metabolism—PHGDH—melanoma	0.00134	0.00233	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—LUM—melanoma	0.00134	0.00233	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—UGT2B10—melanoma	0.00134	0.00233	CbGpPWpGaD
Propylthiouracil—Vomiting—Carmustine—melanoma	0.00133	0.00313	CcSEcCtD
Propylthiouracil—Nausea—Dactinomycin—melanoma	0.00133	0.00312	CcSEcCtD
Propylthiouracil—DBH—Metabolism—HS3ST5—melanoma	0.00132	0.00231	CbGpPWpGaD
Propylthiouracil—Rash—Carmustine—melanoma	0.00132	0.0031	CcSEcCtD
Propylthiouracil—Dermatitis—Carmustine—melanoma	0.00132	0.0031	CcSEcCtD
Propylthiouracil—Thrombocytopenia—Docetaxel—melanoma	0.00132	0.0031	CcSEcCtD
Propylthiouracil—Headache—Carmustine—melanoma	0.00131	0.00308	CcSEcCtD
Propylthiouracil—DIO1—Metabolism—HPSE—melanoma	0.00131	0.00229	CbGpPWpGaD
Propylthiouracil—MPO—IL23-mediated signaling events—PIK3CA—melanoma	0.00131	0.00227	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—CUBN—melanoma	0.00129	0.00225	CbGpPWpGaD
Propylthiouracil—Vomiting—Temozolomide—melanoma	0.00129	0.00303	CcSEcCtD
Propylthiouracil—Rash—Temozolomide—melanoma	0.00128	0.003	CcSEcCtD
Propylthiouracil—Dermatitis—Temozolomide—melanoma	0.00128	0.003	CcSEcCtD
Propylthiouracil—Headache—Temozolomide—melanoma	0.00127	0.00298	CcSEcCtD
Propylthiouracil—Nausea—Carmustine—melanoma	0.00125	0.00292	CcSEcCtD
Propylthiouracil—DIO1—Metabolism—SDHD—melanoma	0.00124	0.00217	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—CSPG4—melanoma	0.00124	0.00217	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—BSG—melanoma	0.00124	0.00217	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—HS3ST5—melanoma	0.00124	0.00217	CbGpPWpGaD
Propylthiouracil—MPO—Folate Metabolism—IL2—melanoma	0.00124	0.00216	CbGpPWpGaD
Propylthiouracil—Musculoskeletal discomfort—Docetaxel—melanoma	0.00123	0.00288	CcSEcCtD
Propylthiouracil—MPO—Selenium Micronutrient Network—ALB—melanoma	0.00121	0.00211	CbGpPWpGaD
Propylthiouracil—Paraesthesia—Docetaxel—melanoma	0.00121	0.00284	CcSEcCtD
Propylthiouracil—DIO1—Metabolism—GPAM—melanoma	0.00121	0.0021	CbGpPWpGaD
Propylthiouracil—Nausea—Temozolomide—melanoma	0.0012	0.00283	CcSEcCtD
Propylthiouracil—Somnolence—Docetaxel—melanoma	0.0012	0.00281	CcSEcCtD
Propylthiouracil—Dyspepsia—Docetaxel—melanoma	0.00119	0.00279	CcSEcCtD
Propylthiouracil—MPO—C-MYB transcription factor network—CDKN2A—melanoma	0.00118	0.00205	CbGpPWpGaD
Propylthiouracil—MPO—C-MYB transcription factor network—BCL2—melanoma	0.00116	0.00202	CbGpPWpGaD
Propylthiouracil—MPO—Folate Metabolism—NFKB1—melanoma	0.00116	0.00202	CbGpPWpGaD
Propylthiouracil—MPO—IL23-mediated signaling events—IL6—melanoma	0.00116	0.00201	CbGpPWpGaD
Propylthiouracil—MPO—C-MYB transcription factor network—CD4—melanoma	0.00111	0.00193	CbGpPWpGaD
Propylthiouracil—MPO—Vitamin B12 Metabolism—TNF—melanoma	0.00111	0.00193	CbGpPWpGaD
Propylthiouracil—MPO—Selenium Micronutrient Network—IFNG—melanoma	0.00111	0.00193	CbGpPWpGaD
Propylthiouracil—MPO—C-MYB transcription factor network—PTGS2—melanoma	0.0011	0.00192	CbGpPWpGaD
Propylthiouracil—Body temperature increased—Docetaxel—melanoma	0.00107	0.0025	CcSEcCtD
Propylthiouracil—MPO—Selenium Micronutrient Network—PTGS2—melanoma	0.00106	0.00185	CbGpPWpGaD
Propylthiouracil—MPO—C-MYB transcription factor network—CDKN1B—melanoma	0.00104	0.00182	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—PLA2G6—melanoma	0.00103	0.00179	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—PLCB4—melanoma	0.001	0.00175	CbGpPWpGaD
Propylthiouracil—MPO—C-MYB transcription factor network—CCND1—melanoma	0.000995	0.00173	CbGpPWpGaD
Propylthiouracil—MPO—C-MYB transcription factor network—CDKN1A—melanoma	0.000962	0.00168	CbGpPWpGaD
Propylthiouracil—Pruritus—Docetaxel—melanoma	0.000953	0.00224	CcSEcCtD
Propylthiouracil—DBH—Metabolism—PIP4K2A—melanoma	0.000943	0.00164	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—SLC6A11—melanoma	0.000943	0.00164	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—PLCB4—melanoma	0.000943	0.00164	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—VCAN—melanoma	0.000921	0.0016	CbGpPWpGaD
Propylthiouracil—MPO—Selenium Micronutrient Network—NFKB1—melanoma	0.000921	0.0016	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—MTAP—melanoma	0.000918	0.0016	CbGpPWpGaD
Propylthiouracil—MPO—Folate Metabolism—TNF—melanoma	0.000901	0.00157	CbGpPWpGaD
Propylthiouracil—MPO—Vitamin B12 Metabolism—IL6—melanoma	0.000894	0.00156	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—SLC6A11—melanoma	0.000887	0.00155	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—PIP4K2A—melanoma	0.000887	0.00155	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—MTAP—melanoma	0.000863	0.0015	CbGpPWpGaD
Propylthiouracil—Vomiting—Docetaxel—melanoma	0.000857	0.00201	CcSEcCtD
Propylthiouracil—MPO—C-MYB transcription factor network—NRAS—melanoma	0.000857	0.00149	CbGpPWpGaD
Propylthiouracil—Rash—Docetaxel—melanoma	0.00085	0.002	CcSEcCtD
Propylthiouracil—Dermatitis—Docetaxel—melanoma	0.000849	0.00199	CcSEcCtD
Propylthiouracil—Headache—Docetaxel—melanoma	0.000844	0.00198	CcSEcCtD
Propylthiouracil—DBH—Metabolism—LUM—melanoma	0.000818	0.00142	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—PHGDH—melanoma	0.000818	0.00142	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—HPSE—melanoma	0.000802	0.0014	CbGpPWpGaD
Propylthiouracil—Nausea—Docetaxel—melanoma	0.0008	0.00188	CcSEcCtD
Propylthiouracil—MPO—C-MYB transcription factor network—MYC—melanoma	0.000798	0.00139	CbGpPWpGaD
Propylthiouracil—MPO—Folate Metabolism—TP53—melanoma	0.000795	0.00138	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—CUBN—melanoma	0.000787	0.00137	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—CYP17A1—melanoma	0.000777	0.00135	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—PHGDH—melanoma	0.000769	0.00134	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—LUM—melanoma	0.000769	0.00134	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—SDHD—melanoma	0.00076	0.00132	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—CSPG4—melanoma	0.00076	0.00132	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—BSG—melanoma	0.00076	0.00132	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—HPSE—melanoma	0.000754	0.00131	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—CUBN—melanoma	0.00074	0.00129	CbGpPWpGaD
Propylthiouracil—MPO—C-MYB transcription factor network—KRAS—melanoma	0.000737	0.00128	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—GPAM—melanoma	0.000737	0.00128	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—GNA11—melanoma	0.000734	0.00128	CbGpPWpGaD
Propylthiouracil—MPO—Folate Metabolism—IL6—melanoma	0.000727	0.00127	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—FASN—melanoma	0.000718	0.00125	CbGpPWpGaD
Propylthiouracil—MPO—Selenium Micronutrient Network—TNF—melanoma	0.000716	0.00125	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—BSG—melanoma	0.000715	0.00125	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—SDHD—melanoma	0.000715	0.00125	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—CSPG4—melanoma	0.000715	0.00125	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—SLC5A5—melanoma	0.000706	0.00123	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—GPAM—melanoma	0.000692	0.00121	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—GNAQ—melanoma	0.000682	0.00119	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—CD44—melanoma	0.000682	0.00119	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—CYP1B1—melanoma	0.000654	0.00114	CbGpPWpGaD
Propylthiouracil—MPO—C-MYB transcription factor network—HRAS—melanoma	0.000627	0.00109	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—PLA2G6—melanoma	0.000626	0.00109	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—PLA2G6—melanoma	0.000589	0.00103	CbGpPWpGaD
Propylthiouracil—MPO—Selenium Micronutrient Network—IL6—melanoma	0.000578	0.00101	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—VCAN—melanoma	0.000563	0.00098	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—ABCB1—melanoma	0.000539	0.000938	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—VCAN—melanoma	0.000529	0.000921	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—PRKCA—melanoma	0.000496	0.000863	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—ERCC2—melanoma	0.000492	0.000856	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—CYP17A1—melanoma	0.000475	0.000827	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—GNA11—melanoma	0.000448	0.000781	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—CYP17A1—melanoma	0.000446	0.000777	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—FASN—melanoma	0.000439	0.000764	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—SLC5A5—melanoma	0.000431	0.000751	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—GNA11—melanoma	0.000421	0.000734	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—CD44—melanoma	0.000417	0.000726	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—GNAQ—melanoma	0.000417	0.000726	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—FASN—melanoma	0.000412	0.000718	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—SLC5A5—melanoma	0.000406	0.000707	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—CYP1B1—melanoma	0.000399	0.000696	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—GNAQ—melanoma	0.000392	0.000682	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—CD44—melanoma	0.000392	0.000682	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—PIK3CG—melanoma	0.000388	0.000676	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—CYP1B1—melanoma	0.000376	0.000654	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—PPARG—melanoma	0.000375	0.000653	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—PIK3CD—melanoma	0.000341	0.000594	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—ALB—melanoma	0.000337	0.000587	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—ABCB1—melanoma	0.000329	0.000573	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—ABCB1—melanoma	0.000309	0.000539	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—PRKCA—melanoma	0.000303	0.000527	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—ERCC2—melanoma	0.0003	0.000523	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—PIK3CB—melanoma	0.000297	0.000518	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—PTGS2—melanoma	0.000295	0.000513	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—PRKCA—melanoma	0.000285	0.000496	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—ERCC2—melanoma	0.000282	0.000492	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—PTEN—melanoma	0.000257	0.000448	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—PIK3CG—melanoma	0.000237	0.000413	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—PPARG—melanoma	0.000229	0.000399	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—PIK3CG—melanoma	0.000223	0.000388	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—PPARG—melanoma	0.000215	0.000375	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—PIK3CD—melanoma	0.000208	0.000363	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—ALB—melanoma	0.000206	0.000358	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—PIK3CD—melanoma	0.000196	0.000341	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—ALB—melanoma	0.000193	0.000337	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—PIK3CB—melanoma	0.000182	0.000316	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—PIK3CA—melanoma	0.000181	0.000316	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—PTGS2—melanoma	0.00018	0.000314	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—PIK3CB—melanoma	0.000171	0.000298	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—PTGS2—melanoma	0.000169	0.000295	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—PTEN—melanoma	0.000157	0.000273	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—AKT1—melanoma	0.000148	0.000258	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—PTEN—melanoma	0.000148	0.000257	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—PIK3CA—melanoma	0.000111	0.000193	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—PIK3CA—melanoma	0.000104	0.000181	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—AKT1—melanoma	9.05e-05	0.000158	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—AKT1—melanoma	8.51e-05	0.000148	CbGpPWpGaD
